Literature DB >> 4472237

Plasma dopa concentrations and the "on-off" effect after chronic treatment of Parkinson's disease.

R D Sweet, F H McDowell.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1974        PMID: 4472237     DOI: 10.1212/wnl.24.10.953

Source DB:  PubMed          Journal:  Neurology        ISSN: 0028-3878            Impact factor:   9.910


× No keyword cloud information.
  21 in total

1.  Current therapy of Parkinson's disease.

Authors:  J C Ramseyer
Journal:  West J Med       Date:  1975-08

2.  A double-blind crossover comparison of Sinemet CR4 and standard Sinemet 25/100 in patients with Parkinson's disease and fluctuating motor performance.

Authors:  J M Cedarbaum; M Hoey; F H McDowell
Journal:  J Neurol Neurosurg Psychiatry       Date:  1989-02       Impact factor: 10.154

3.  Editorial: Alternatives to levodopa.

Authors: 
Journal:  Br Med J       Date:  1976-05-15

4.  Sustained-release of levodopa: single dose study of a new formulation.

Authors:  M Gerlach; W Kuhn; T Müller; P Klotz; H Przuntek
Journal:  J Neural Transm (Vienna)       Date:  1996       Impact factor: 3.575

5.  Madopar HBS and the decompensated phase of Parkinson disease.

Authors:  T Caraceni; N Nordera; E Lamperti; A Lorizio
Journal:  Ital J Neurol Sci       Date:  1989-08

Review 6.  Clinical pharmacokinetics of anti-parkinsonian drugs.

Authors:  J M Cedarbaum
Journal:  Clin Pharmacokinet       Date:  1987-09       Impact factor: 6.447

Review 7.  Clinical pharmacokinetics of levodopa in parkinson's disease.

Authors:  J R Bianchine; G M Shaw
Journal:  Clin Pharmacokinet       Date:  1976       Impact factor: 6.447

8.  "On-off" phenomenon in Parkinson's disease: correlation to the concentration of dopa in plasma.

Authors:  T Eriksson; T Magnusson; A Carlsson; A Linde; A K Granérus
Journal:  J Neural Transm       Date:  1984       Impact factor: 3.575

Review 9.  Anti-parkinsonian drugs today.

Authors:  N P Quinn
Journal:  Drugs       Date:  1984-09       Impact factor: 9.546

10.  Treatment of Parkinson's disease: problems with a progressing disease.

Authors:  U K Rinne
Journal:  J Neural Transm       Date:  1981       Impact factor: 3.575

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.